Current role
Biotechnology · Healthcare
Chairman, Board Member
2021-08-02–present
Amy W. Schulman
Chairman
Alnylam Pharmaceuticals, Inc. (ALNY)Board Member
Alnylam Pharmaceuticals, Inc. (ALNY)Equibles does not estimate personal net worth.
Get an email with a short summary when Alnylam Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALNY alertsAbout Amy W. Schulman
Amy W. Schulman is recorded as Chairman at Alnylam Pharmaceuticals, Inc. (ALNY) since January 5, 2023 and Board Member at Alnylam Pharmaceuticals, Inc. (ALNY) since August 2, 2021. Alnylam Pharmaceuticals, Inc. reported in an 8-K filed January 6, 2023 that Amy W. Schulman was appointed Chair of the Board, effective January 5, 2023. Alnylam Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alnylam Pharmaceuticals, Inc. includes Yvonne Greenstreet (CEO and COO), Yvonne L. Greenstreet (CEO, COO and Board Member), Michael Bonney (Chairman) and 7 others.
“Amy W. Schulman, the Lead Independent Director, has been appointed by the Board to serve as Chair of the Board.”
Affiliation history
-
Current
2023-01-05–present
-
Current
2021-08-02–present
Company network
Leadership on record at Alnylam Pharmaceuticals, Inc.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member